Clinical Trial

A Telenursing Program to Support Diabetes Self-Management

Completed
View on ClinicalTrials.gov →
Summary
This randomized controlled trial aims to develop and evaluate a telenursing-based Diabetes Self-Management Education and Support (DSMES) program with uncontrolled type 2 diabetes mellitus in Thailand. The program is designed to improve diabetes self-management through nurse-led education, behavioral support, and regular follow-up delivered via telecommunication technologies. Participants with type 2 diabetes and poor glycemic control will be randomly assigned to either an intervention group receiving a 12-week telenursing DSMES program or a control group receiving usual care. The intervention includes an initial in-person education session followed by structured video call follow-ups provided by nurse. The primary outcome of this study is the feasibility of implementing telenursing for DSMES in Thailand. Secondary outcomes include changes in glycemic control (HbA1C , FBG), blood pressure, body mass index, diabetes knowledge, self-care behaviors, coping behaviors, quality of life, healthcare costs, and frequency of acute care use. The findings from this study are expected to provide evidence to support the use of telenursing as an accessible and sustainable approach for diabetes self-management in the Thai healthcare context.
Protocol Amendment History 1 change
critical Trial completed 2026-06-27
Trial Details
NCT Number NCT07366775
Lead Sponsor Chiang Mai University
Conditions Type 2 Diabetes Mellitus (T2DM)
Enrollment 128 participants
Start Date 2026-02-25
Primary Completion 2026-06-08 (estimated)
Study Completion 2026-06-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-26